Amneal Makes It Three With Pegfilgrastim Approval

Third US Biosimilar Fylnetra Follows FDA Nods For Filgrastim And Bevacizumab

 
• By David Wallace
  
Neon number 3 on black background
Good things have come in threes for Amneal’s biosimilars business • Source: Shutterstock

More from Biosimilars

More from Products